Develop and manage intercompany funding and settlement processes to support the Company's evolving global operations, including intercompany loans, cash transfers, funding requirements, and cash repatriation; partner closely with Tax, Accounting, and Legal to evaluate funding alternatives and establish appropriate documentation, controls, and processes considering tax, accounting, regulatory, and legal-entity requirements. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis and uterine fibroids , as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas.